Your shopping cart is currently empty

M826, a non-peptide, potent, selective, and reversible caspase-3 inhibitor, exhibits an IC50 of 0.005 μM and demonstrates strong anti-apoptotic activity in vitro and in vivo animal models. It is useful for research into nervous system diseases [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $1,590 | 10-14 weeks | 10-14 weeks | |
| 5 mg | $3,200 | 10-14 weeks | 10-14 weeks | |
| 10 mg | $4,130 | 10-14 weeks | 10-14 weeks | |
| 25 mg | $5,830 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $7,558 | 10-14 weeks | 10-14 weeks |
| Description | M826, a non-peptide, potent, selective, and reversible caspase-3 inhibitor, exhibits an IC50 of 0.005 μM and demonstrates strong anti-apoptotic activity in vitro and in vivo animal models. It is useful for research into nervous system diseases [1]. |
| In vitro | M826 inhibits apoptosis in NT2 cells at varying concentrations after 20-hour exposure [1]. |
| In vivo | M826 (30 nmol, intraventricular injection) inhibits the activation of Caspase-3 and the cleavage of its substrates in a neonatal hypoxia-ischemia (H-I) rat model [1]. |
| Molecular Weight | 575.7 |
| Formula | C28H45N7O6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.